Similar articles

• Serologic Screening for Genital Herpes Infection: US Preventive Services Task Force Recommendation Statement.

  US Preventive Services Task Force; Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW Jr, García FA, Kemper AR, Krist AH, Kurth AE, Landefeld CS, Mangione CM, Phillips WR, Phipps MG, Pignone MP, Silverstein M, Tseng CW. US Preventive Services Task Force, et al. JAMA. 2016 Dec 20;316(23):2525-2530. doi: 10.1001/jama.2016.16776. JAMA. 2016. PMID: 27997659
• A Recommendation Against Serologic Screening for Genital Herpes Infection-What Now?

  Hook EW 3rd. Hook EW 3rd. JAMA. 2016 Dec 20;316(23):2493-2494. doi: 10.1001/jama.2016.17139. JAMA. 2016. PMID: 27997636 No abstract available.
• Herpes simplex virus-type 2 seropositivity in a Danish adult population denying previous episodes of genital herpes.

  Petersen CS, Larsen FG, Zachariae C, Heidenheim M. Petersen CS, et al. Acta Derm Venereol. 2000 Mar-Apr;80(2):158. Acta Derm Venereol. 2000. PMID: 10877149 No abstract available.
• [Genital herpes in immunocompetent men and non-pregnant women Clinical aspects, accuracy of clinical examination, evolution].

  Janier M. Janier M. Ann Dermatol Venereol. 2002 Apr;129(4 Pt 2):586-96. Ann Dermatol Venereol. 2002. PMID: 12122328 Review. French.
• Short-course therapy for recurrent genital herpes and herpes labialis.

  Spruance S, Aoki FY, Tyring S, Stanberry L, Whitley R, Hamed K. Spruance S, et al. J Fam Pract. 2007 Jan;56(1):30-6. J Fam Pract. 2007. PMID: 17217895 Review. No abstract available.